SCIB logo

SciBase Holding AB (publ) Stock Price

OM:SCIB Community·SEK 156.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SCIB Share Price Performance

SEK 0.38
0.03 (8.62%)
SEK 0.38
0.03 (8.62%)
Price SEK 0.38

SCIB Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
1 Reward

SciBase Holding AB (publ) Key Details

SEK 36.6m

Revenue

SEK 12.4m

Cost of Revenue

SEK 24.2m

Gross Profit

SEK 114.6m

Other Expenses

-SEK 90.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 24, 2026
-0.22
66.04%
-247.08%
0%
View Full Analysis

About SCIB

Founded
1998
Employees
38
CEO
Pia Renaudin
WebsiteView website
scibase.com

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Nevisense; Vrije Universiteit Brussel University hospitals for a study geared toward predicting atopic dermatitis and concomitant atopic diseases, such as asthma and hay fever in infants. SciBase Holding AB (publ) was founded in 1998 and is headquartered in Sundbyberg, Sweden.

Recent SCIB News & Updates

Recent updates

No updates